HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bahman Yousefi Selected Research

Carbohydrates

12/2020Effects of chitosan and oligochitosans on the phosphatidylinositol 3-kinase-AKT pathway in cancer therapy.
9/2020Importance of the Microbiota Inhibitory Mechanism on the Warburg Effect in Colorectal Cancer Cells.
3/2020Carbohydrate polymer-based silver nanocomposites: Recent progress in the antimicrobial wound dressings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bahman Yousefi Research Topics

Disease

108Neoplasms (Cancer)
09/2022 - 03/2014
16Osteosarcoma (Osteogenic Sarcoma)
09/2022 - 11/2020
15Inflammation (Inflammations)
01/2022 - 02/2017
14Breast Neoplasms (Breast Cancer)
04/2021 - 09/2014
13Neoplasm Metastasis (Metastasis)
04/2022 - 01/2018
12Carcinogenesis
07/2022 - 01/2019
12Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 01/2015
5COVID-19
04/2022 - 08/2020
5Leukemia
01/2022 - 01/2015
5Genomic Instability
01/2022 - 11/2018
5Infections
07/2020 - 01/2019
4Cardiovascular Diseases (Cardiovascular Disease)
07/2021 - 09/2014
4Stomach Neoplasms (Stomach Cancer)
01/2021 - 02/2019
4Ischemia
01/2021 - 06/2014
4Rheumatoid Arthritis
12/2019 - 03/2013
4Colonic Neoplasms (Colon Cancer)
10/2019 - 01/2014
3Cytokine Release Syndrome
08/2022 - 12/2020
3Type 2 Diabetes Mellitus (MODY)
04/2022 - 12/2017
3Hemolysis
01/2022 - 01/2019
3Hypoxia (Hypoxemia)
05/2020 - 03/2018
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019 - 01/2015
3Hepatocellular Carcinoma (Hepatoma)
02/2018 - 01/2012
3Myocardial Reperfusion Injury
02/2017 - 06/2014
2Disseminated Intravascular Coagulation
08/2022 - 01/2021
2Insulin Resistance
04/2022 - 01/2019
2Diabetes Complications
04/2022 - 11/2019
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2022 - 01/2019
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 06/2020
2Pathologic Processes
01/2022 - 01/2019
2Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2019
2Glioma (Gliomas)
01/2022 - 01/2021
2Fibrosis (Cirrhosis)
11/2021 - 01/2020
2Prostatic Neoplasms (Prostate Cancer)
10/2021 - 05/2017
2Virus Diseases (Viral Diseases)
09/2021 - 01/2019
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
06/2021 - 02/2019

Drug/Important Bio-Agent (IBA)

22MicroRNAs (MicroRNA)IBA
04/2022 - 11/2016
17Proteins (Proteins, Gene)FDA Link
04/2022 - 03/2014
14MelatoninIBA
07/2022 - 08/2017
10Biological ProductsIBA
04/2022 - 01/2015
10DNA (Deoxyribonucleic Acid)IBA
03/2022 - 03/2014
9QuercetinIBA
09/2022 - 01/2018
9Pharmaceutical PreparationsIBA
07/2022 - 01/2016
9AntioxidantsIBA
10/2021 - 01/2015
9Doxorubicin (Adriamycin)FDA LinkGeneric
08/2021 - 10/2017
8PolyphenolsIBA
09/2022 - 10/2019
8EnzymesIBA
03/2022 - 03/2013
8ChitosanIBA
01/2022 - 05/2020
7Interleukin-6 (Interleukin 6)IBA
08/2022 - 06/2014
7Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2019
7Peroxisome Proliferator-Activated Receptors (PPAR)IBA
05/2019 - 04/2013
6Methotrexate (Mexate)FDA LinkGeneric
09/2022 - 01/2019
6Antineoplastic Agents (Antineoplastics)IBA
06/2022 - 01/2016
6CateninsIBA
04/2022 - 01/2017
5CurcuminIBA
04/2022 - 02/2021
5PhytochemicalsIBA
04/2022 - 01/2020
5Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022 - 10/2014
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 05/2017
5LipidsIBA
01/2020 - 03/2013
4thymoquinoneIBA
09/2022 - 10/2021
4Cisplatin (Platino)FDA LinkGeneric
09/2022 - 03/2022
4FlavonoidsIBA
09/2022 - 01/2018
4Circular RNAIBA
07/2022 - 01/2020
4LigandsIBA
05/2022 - 01/2016
4Antiviral Agents (Antivirals)IBA
04/2022 - 01/2019
4Phosphotransferases (Kinase)IBA
11/2021 - 01/2012
4Mitogen-Activated Protein KinasesIBA
01/2020 - 01/2012
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2022 - 02/2017
3CytokinesIBA
08/2022 - 12/2019
3Therapeutic UsesIBA
04/2022 - 07/2020
3ResveratrolIBA
01/2022 - 01/2015
3Long Noncoding RNAIBA
11/2021 - 01/2021
31,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
03/2021 - 01/2020
3Dimenhydrinate (DMH)FDA LinkGeneric
03/2021 - 01/2020
3SurvivinIBA
01/2021 - 09/2014
3Small Interfering RNA (siRNA)IBA
01/2021 - 10/2018
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2020 - 01/2019
3CarbohydratesIBA
12/2020 - 03/2020
3Transforming Growth Factors (Transforming Growth Factor)IBA
05/2020 - 01/2020
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2019 - 12/2017
3Member 1 Subfamily B ATP Binding Cassette TransporterIBA
04/2018 - 03/2016
2Dacarbazine (DIC)FDA LinkGeneric
08/2022 - 01/2021
2NucleotidesIBA
04/2022 - 09/2020
2Oxygen (Dioxygen)IBA
04/2022 - 03/2018
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2022 - 10/2020
2Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 03/2019
2Hematoxylin (Haematoxylon)IBA
01/2022 - 03/2019
2Free RadicalsIBA
01/2022 - 11/2018
2InterleukinsIBA
01/2022 - 02/2017
2Polysaccharides (Glycans)IBA
01/2022 - 03/2020
2BerberineIBA
01/2022 - 04/2020
2Vitamin DFDA LinkGeneric
09/2021 - 09/2014
2Hormones (Hormone)IBA
06/2021 - 01/2021
2Messenger RNA (mRNA)IBA
10/2020 - 05/2017
2Telomerase (Telomerase Reverse Transcriptase)IBA
10/2020 - 05/2017
2Glucose (Dextrose)FDA LinkGeneric
09/2020 - 01/2020
2Cytotoxins (Cytolysins)IBA
08/2020 - 02/2019

Therapy/Procedure

53Therapeutics
09/2022 - 03/2014
27Drug Therapy (Chemotherapy)
07/2022 - 01/2015
9Radiotherapy
01/2022 - 03/2018
3Immunotherapy
11/2020 - 02/2019